Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
26 hedge funds and large institutions have $2.19M invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 26 → 26 (0)
1.53% less ownership
Funds ownership: 74.94% → 73.41% (-1.5%)
6% less capital invested
Capital invested by funds: $2.34M → $2.19M (-$151K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAM
Decagon Asset Management
London,
United Kingdom
|
+$6.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$24.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$19.5K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$6.3K |
| 4 |
GAM
Gritstone Asset Management
Bethesda,
Maryland
|
-$602 |
OACCW Hedge Fund Activity: Q3 2025 in Review
26 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q3 2025, worth a combined $2.19M — down 6.5% from $2.34M a quarter earlier.
Fund positioning in OACCW was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was Decagon Asset Management, adding an estimated $6.37K. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $24.7K.
- 26 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $2.19M of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q3 2025, down 6.5% quarter-over-quarter.
- 0 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q3 2025 and 0 closed out.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q3 2025 was Decagon Asset Management, an estimated $6.37K added.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant seller in Q3 2025 was Schonfeld Strategic Advisors, an estimated $24.7K sold.
Based on aggregated 13F filings for Q3 2025.